Five Year Outcomes in Patients with End Stage Renal Disease Who Received a Bioengineered Human Acellular Vessel for Dialysis Access

OBJECTIVE: Patients with end stage renal failure who require haemodialysis suffer morbidity and mortality due to vascular access. Bioengineered human acellular vessels (HAVs) may provide a haemodialysis access option with fewer complications than other grafts. In a prospective phase II trial from 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Jakimowicz, Tomasz, Przywara, Stanislaw, Turek, Jakub, Pilgrim, Alison, Macech, Michal, Zapotoczny, Norbert, Zubilewicz, Tomasz, Lawson, Jeffrey H., Niklason, Laura E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881722/
https://www.ncbi.nlm.nih.gov/pubmed/35243473
http://dx.doi.org/10.1016/j.ejvsvf.2022.01.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881722/
https://www.ncbi.nlm.nih.gov/pubmed/35243473
http://dx.doi.org/10.1016/j.ejvsvf.2022.01.003

Ejemplares similares